A detailed history of Palo Alto Investors LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 210,258 shares of SRPT stock, worth $25.6 Million. This represents 3.61% of its overall portfolio holdings.

Number of Shares
210,258
Previous 201,683 4.25%
Holding current value
$25.6 Million
Previous $31.9 Million 17.59%
% of portfolio
3.61%
Previous 4.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$124.33 - $156.75 $1.07 Million - $1.34 Million
8,575 Added 4.25%
210,258 $26.3 Million
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $47,371 - $68,489
418 Added 0.21%
201,683 $31.9 Million
Q1 2024

May 15, 2024

BUY
$93.7 - $141.53 $33,732 - $50,950
360 Added 0.18%
201,265 $26.1 Million
Q4 2023

Feb 14, 2024

BUY
$67.31 - $124.76 $7.19 Million - $13.3 Million
106,875 Added 113.66%
200,905 $19.4 Million
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $10 Million - $14.8 Million
94,030 New
94,030 $10.8 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.